Dcaf13-KO Mouse
Common Name
Dcaf13-KO
제품 ID
S-KO-05693
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-223499-Dcaf13-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Dcaf13-KO Mouse (카탈로그 번호 S-KO-05693)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Dcaf13-KO
품종 계통계통 ID
KOCMP-223499-Dcaf13-B6J-VA
유전자명
제품 ID
S-KO-05693
유전자 별칭
Gm83, Wdsof1
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 15
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000022909
NCBI 전사체 ID
NM_198606
타겟 영역
Exon 2~6
유효 영역 크기
~9.8 kb
유전자 연구 개요
DCAF13, short for DDB1 and CUL4 associated factor 13, is a substrate receptor of the E3 ubiquitin ligase CRL4. It is involved in ubiquitination processes, which play crucial roles in regulating protein stability, function, and degradation, thus impacting various biological pathways and cellular functions [1,2,3,4]. Ubiquitination is essential for normal regulation of many biological functions such as cell cycle progression, DNA damage repair, and embryo development [4,5].
In disease-related research, DCAF13 has been found to be highly expressed in lung adenocarcinoma, ovarian cancer, and breast cancer, promoting cancer progression. In lung adenocarcinoma, it inhibits the p53 signaling pathway by promoting p53 ubiquitination and degradation, thus facilitating cancer cell proliferation and migration [1]. In ovarian cancer, it activates the FRAS1-mediated FAK signaling pathway by targeting FRAS1 for polyubiquitination and proteasomal degradation [2]. In breast cancer, it promotes cell proliferation by ubiquitin-inhibiting PERP expression [4]. Additionally, in preeclampsia, abnormal expression of DCAF13 affects endometrial decidualization, which may be involved in the occurrence and development of this pregnancy-related disorder [6]. In terms of embryo development, knockdown of DCAF13 in porcine embryos decreased blastocyst-stage development, affecting histone methylation-related gene expression and DNA damage repair [5]. In mice, uterine decidualization failed in pseudopregnant conditional Dcaf13 knockout mice, indicating its key role in decidualization [6]. Maternal-specific deletion of DCAF13 in mouse oocytes led to abnormal chromatin condensation and transcription in zygotic embryos, arresting development at the two-cell stage [7].
In summary, DCAF13 is essential for multiple biological processes, with its dysregulation contributing to various diseases. Gene knockout and conditional knockout mouse models have been pivotal in revealing its roles in cancer progression, embryo development, and preeclampsia, providing insights into potential therapeutic targets and disease mechanisms.
References:
1. Wei, Shan, Xing, Jing, Chen, Jia, Wang, Kai, Yu, Wanjun. 2024. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma. In Journal of experimental & clinical cancer research : CR, 43, 3. doi:10.1186/s13046-023-02936-2. https://pubmed.ncbi.nlm.nih.gov/38163876/
2. Tang, Ze-Yi, Wang, Xiao-Min, Xu, Chun-Wei, Cheng, Shu-Qun, Pan, Wei-Wei. 2024. DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway. In Cellular and molecular life sciences : CMLS, 81, 421. doi:10.1007/s00018-024-05446-2. https://pubmed.ncbi.nlm.nih.gov/39367995/
3. Ren, Peipei, Tong, Xiaomei, Li, Junjian, Zhang, Songying, Zhang, Yin-Li. 2024. CRL4DCAF13 E3 ubiquitin ligase targets MeCP2 for degradation to prevent DNA hypermethylation and ensure normal transcription in growing oocytes. In Cellular and molecular life sciences : CMLS, 81, 165. doi:10.1007/s00018-024-05185-4. https://pubmed.ncbi.nlm.nih.gov/38578457/
4. Shan, Bao-Qian, Wang, Xiao-Min, Zheng, Li, Pan, Wei-Wei, Zhang, Xin. 2022. DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression. In Cancer science, 113, 1587-1600. doi:10.1111/cas.15300. https://pubmed.ncbi.nlm.nih.gov/35178836/
5. da Silva, Zigomar, Glanzner, Werner Giehl, Gutierrez, Karina, Gonçalves, Paulo Bayard Dias, Bordignon, Vilceu. 2023. DCAF13 and RNF114 participate in the regulation of early porcine embryo development. In Reproduction (Cambridge, England), 166, 401-410. doi:10.1530/REP-23-0230. https://pubmed.ncbi.nlm.nih.gov/37855431/
6. Yan, Xingyu, Rong, Miaomiao, Zhou, Qianhui, Zhang, Cong. 2022. DCAF13 is essential for the pathogenesis of preeclampsia through its involvement in endometrial decidualization. In Molecular and cellular endocrinology, 556, 111741. doi:10.1016/j.mce.2022.111741. https://pubmed.ncbi.nlm.nih.gov/35932979/
7. Liu, Yang, Zhao, Long-Wen, Shen, Jing-Ling, Fan, Heng-Yu, Jin, Yan. 2019. Maternal DCAF13 Regulates Chromatin Tightness to Contribute to Embryonic Development. In Scientific reports, 9, 6278. doi:10.1038/s41598-019-42179-w. https://pubmed.ncbi.nlm.nih.gov/31000741/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
